Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
45 studies found for:    "methodist hospital" | Open Studies | "Vascular Diseases" | United States, Texas | Houston
Show Display Options
Rank Status Study
1 Recruiting Reducing Radioisotope Dose: the Half-Dose CZT Study
Condition: Coronary Artery Disease
Intervention: Other: Half-dose isotope for NuclearStressTest
2 Recruiting Effectiveness of Vitamin D Supplementation
Conditions: Elevated Blood Pressure;   Endothelial Dysfunction
Intervention: Dietary Supplement: 2,000 International Units (IU)of vitamin D3
3 Recruiting Diagnostic Study of Rapid Regadenoson Stress Cardiovascular Magnetic Resonance (CMR) to Detect Coronary Artery Disease
Condition: Coronary Artery Disease
Intervention: Drug: regadenoson
4 Recruiting Registry of the Magellan Robotic System
Condition: Peripheral Vascular Disease
Intervention:
5 Recruiting TUMOR-ASSOCIATED ANTIGEN-SPECIFIC CYTOTOXIC T-LYMPHOCYTES FOR MULTIPLE MYELOMA
Condition: Multiple Myeloma
Intervention: Biological: TAA-specific CTLs
6 Recruiting Role of CYP2C19 Polymorphism in the Drug Interaction Between Clopidogrel and Omeprazole
Condition: Coronary Artery Disease
Intervention: Drug: Clopidogrel 75mg, Omeprazole 20mg
7 Recruiting Kappa-CD28 T Lymphocytes, Chronic Lymphocytic Leukemia, B-cell Lymphoma or Multiple Myeloma, CHARKALL
Conditions: Lymphoma;   Myeloma;   Leukemia
Intervention: Biological: Kappa CD28 T cells
8 Available Safety and Efficacy of Autologous Concentrated Bone Marrow Aspirate for Critical Limb Ischemia - Continued Access
Conditions: Peripheral Arterial Disease;   Peripheral Vascular Diseases;   Critical Limb Ischemia
Intervention: Device: Bone marrow concentration device
9 Recruiting Brain Machine Interface Control of an Robotic Exoskeleton in Training Upper Extremity Functions in Stroke
Conditions: Stroke;   Hemiparesis
Intervention: Device: MAHI EXO-II exoskeleton augmented with BMI system
10 Recruiting BEnefits of Stroke Treatment Delivered Using a Mobile Stroke Unit
Condition: Acute Ischemic Stroke
Intervention: Other: Mobile Stroke Unit Management
11 Recruiting A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
Conditions: Catecholamine-resistant Hypotension (CRH);   Distributive Shock;   High Output Shock;   Sepsis
Interventions: Drug: LJPC-501;   Drug: Placebo
12 Recruiting PORtopulmonary Hypertension Treatment wIth maCitentan ─ a randOmized Clinical Trial
Condition: Portopulmonary Hypertension
Interventions: Drug: Macitentan;   Other: Placebo
13 Recruiting Zenith® p-Branch® Endovascular Graft Pivotal Study
Condition: Aortic Aneurysm Abdominal
Intervention: Device: Zenith® p-Branch® in combination with the Atrium iCAST™ covered stents
14 Recruiting Beraprost-314d Added-on to Tyvaso® (BEAT)
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: Beraprost Sodium 314d Modified Release Tablets;   Drug: Placebo
15 Recruiting Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Conditions: Pulmonary Hypertension;   Interstitial Lung Disease;   Combined Pulmonary Fibrosis and Emphysema
Interventions: Drug: Inhaled Treprostinil;   Drug: Placebo
16 Recruiting Clinical Study to Assess the Efficacy and Safety of Macitentan in Patients With Pulmonary Hypertension After Left Ventricular Assist Device Implantation
Condition: Pulmonary Hypertension
Interventions: Drug: Macitentan 10mg;   Drug: Placebo sugar pill
17 Recruiting Valiant Evo US Clinical Trial
Condition: Aortic Aneurysm, Thoracic
Intervention: Device: Valiant Evo Thoracic Stent Graft
18 Recruiting ABSORB III Randomized Controlled Trial (RCT)
Conditions: Coronary Artery Disease;   Coronary Artery Stenosis;   Coronary Disease;   Coronary Stenosis
Interventions: Device: Absorb BVS;   Device: XIENCE
19 Recruiting A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: ubenimex;   Other: placebo
20 Recruiting The Efficacy and Safety of Initial Triple Versus Initial Dual Oral Combination Therapy in Patients With Newly Diagnosed Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: Macitentan;   Drug: Tadalafil;   Drug: Selexipag

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.